Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.chemfabalkalis.com | |
Market Cap | 308.95 Cr. | |
Enterprise Value(EV) | 299.45 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 43.82 | Trailing Twelve Months Ending 2022-12 |
Price-Earning Ratio (PE) | 4.97 | Trailing Twelve Months Ending 2022-12 |
Industry PE | 25.88 | Trailing Twelve Months Ending 2022-12 |
Book Value / Share | 244.57 | Trailing Twelve Months Ending 2022-12 |
Price to Book Value | 0.89 | Calculated using Price: 217.80 |
Dividend Yield | 0.57 | Period Ending 2022-03 |
No. of Shares Subscribed | 1.42 Cr. | 14,182,002 Shares |
FaceValue | 10 | |
Company Profile | ||
Chemfab Alkalis is the first Chloralkali Plant in India, to introduce and successfully implement Ion Exchange Membrane Cell technology for Chlor-alkali production, in 1985. CCAL has upgraded with BiTAC electrolysers, for the first time in India. |
1 Day |
|
+0.60% |
1 Week |
|
-8.43% |
1 Month |
|
-17.90% |
3 Month |
|
-22.77% |
6 Month |
|
-47.75% |
1 Year |
|
-5.24% |
2 Year |
|
+75.57% |
5 Year |
|
|
10 Year |
|
3 years | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 9.25 | -3.00 | 10.20 | |
Return on Capital Employed (%) | 9.52 | 1.56 | 13.34 | |
Return on Assets (%) | 7.56 | -2.47 | 8.56 |
Particulars | 4 years | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 276 | 267 | 298 | 331 | |
Non Curr. Liab. | -15 | 13 | -6 | -31 | |
Curr. Liab. | 76 | 42 | 58 | 51 | |
Minority Int. | |||||
Equity & Liab. | 337 | 322 | 349 | 352 | |
Non Curr. Assets | 259 | 246 | 250 | 223 | |
Curr. Assets | 78 | 76 | 99 | 130 | |
Misc. Exp. not W/O | |||||
Total Assets | 337 | 322 | 349 | 352 |
Particulars | 4 years | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-12 Rs. Cr. TTM |
Net Sales | 205 | 181 | 272 | 346 | |
Other Income | 3 | 1 | 6 | 7 | |
Total Income | 208 | 182 | 277 | 353 | |
Total Expenditure | -149 | -157 | -215 | -241 | |
PBIDT | 59 | 25 | 62 | 112 | |
Interest | -4 | -3 | -1 | 0 | |
Depreciation | -25 | -20 | -22 | -23 | |
Taxation | -1 | -10 | -10 | -23 | |
Exceptional Items | -3 | -3 | |||
PAT | 25 | -8 | 29 | 62 | |
Minority Interest | |||||
Share Associate | |||||
Other Related Items | |||||
Consolidated Net Profit | 25 | -8 | 29 | 62 | |
Adjusted EPS | 18 | -6 | 20 | 44 |
Particulars | 3 years | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 54 | 45 | 55 | |
Cash Fr. Inv. | -58 | -6 | -21 | |
Cash Fr. Finan. | 3 | -16 | -25 | |
Net Change | -1 | 23 | 9 | |
Cash & Cash Eqvt | 0 | 23 | 33 |
Tue, 21 Feb 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation of the Loss of Share Certificate. |
Wed, 15 Feb 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication In line with the requirements of Regulation 47 of SEBI (LODR) Regulations 2015 we have published the Un-Audited Standalone and Consolidated Financial Results for the Quarter and Nine months ended 31st December 2022 in the Business Standard (English Newspaper) and Makkal Kural (Tamil Newspaper) on 09th February 2023. Enclosing the copies of the advertisement published. |
Wed, 08 Feb 2023
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS We wish to inform you that the Board of Directors at the meeting held on 07th February 2023 approved the allotment of 37 000 Equity Shares of Face Value of Rs.10 under the Chemfab Alkalis Employees Stock option scheme (CAESOS 2020) to the employees those who have exercised their options. |
Tue, 28 Mar 2023 |
|
|
|
|
|